Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature - PubMed (original) (raw)

Review

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature

Xiaoqin Yang et al. Clin Rheumatol. 2013 Oct.

Abstract

Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease. Understanding of PAH prevalence remains limited, but PAH has been reported as a frequent complication in connective tissue diseases. This study estimated prevalence of PAH in patients with connective tissue diseases and prevalence of idiopathic PAH using a systematic review of the literature. We searched PubMed through May 19, 2012 for all studies on prevalence of PAH in patients with connective tissue diseases or prevalence of idiopathic PAH. To be included, studies had to be in English, have humans as subjects, and determine prevalence within a time interval of up to 2 years. Studies only investigating pediatric patients were excluded. Pooled prevalence estimates were calculated. Twenty studies were identified in the review. Seventeen of the 20 studies reported prevalence of PAH in connective tissue diseases and three reported prevalence of idiopathic PAH. The pooled prevalence estimate of idiopathic PAH was 12 cases per million population (95 % CI 5 cases per million to 22 cases per million) with estimates ranging from 5.9 cases per million population to 25 cases per million population. The pooled prevalence estimate of PAH in patients with connective tissue diseases was 13 % (95 % CI, 9.18 % to 18.16 %) with reported estimates ranging from 2.8 % to 32 %. Prevalence of PAH in patients with connective tissue diseases was substantially higher than that of idiopathic PAH based on pooled prevalence estimates. Comparisons of PAH prevalence in persons with connective tissue disease and idiopathic PAH using a large observational study would be helpful in better assessing relative prevalence.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Proportion meta-analysis of prevalence of idiopathic pulmonary arterial hypertension for all groups and for subgroup not diagnosed by right heart catheterization

Fig. 2

Fig. 2

Proportion meta-analysis of prevalence of PAH in patients with connective tissue diseases

Fig. 3

Fig. 3

Proportion meta-analysis of prevalence of PAH in patients with systemic sclerosis, lupus, and rheumatoid arthritis

Fig. 4

Fig. 4

Proportion meta-analysis of prevalence of PAH by whether diagnosed by right heart catheterization or echocardiograph in patients with systemic sclerosis

Similar articles

Cited by

References

    1. McLaughlin VV, ACCF/AHA et al. Expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573–1619. doi: 10.1016/j.jacc.2009.01.004. - DOI - PubMed
    1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet. 1998;352(9129):719–725. doi: 10.1016/S0140-6736(98)02111-4. - DOI - PubMed
    1. Baughman RP, Carbone, RG, Bottino G (2009) Pulmonary arterial hypertension and interstitial lung diseases: a clinical guide. R.G.C. Robert P. Baughman, Giovanni Bottino (ed) Humana Press: New York, NY
    1. Kimberly (2001) Primer on the rheumatic diseases. J.H. Klippel (ed) Arthritis Foundation: Atlanta, GA. p. 325–8
    1. Trell E, Lindstrom C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis. 1971;30(4):390–400. doi: 10.1136/ard.30.4.390. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources